Viewing Study NCT03448835


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT03448835
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-08
First Post: 2017-11-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module